Company: AIRJW
Filing Date: 2025-03-25
Form Type: 10-K
Source: 0001013762-25-002263
Chunk: 262

Company: AirJoule Technologies Corp.
Filing Date: 2025-03-25
Form: 10-K
Item: Item 1A
Chunk 262
---
 license or
litigation. In the event that we cannot renew and/or expand existing licenses, we may be required to discontinue or limit our use of the
operations, products, or offerings that include or incorporate the licensed intellectual property. Any such discontinuation or limitation
could have a material and adverse impact on our business, financial condition and results of operation.

Risks Related to our Common Stock and Capital Structure 

Concentration of ownership among our existing executive officers,
directors and their respective affiliates may prevent new investors from influencing significant corporate decisions.

As of December 31, 2024, our executive officers, directors and
their respective affiliates, together, beneficially owned approximately 58.0% of our outstanding common stock. As a result, these stockholders
are able to exercise a significant level of control over all matters requiring stockholder approval, including the election of directors,
amendment of our Charter and approval of significant corporate transactions. This control could have the effect of delaying or preventing
a change of control of us or changes in management and will make the approval of certain transactions difficult or impossible without
the support of these stockholders. Moreover, this concentration of stock ownership by our significant stockholders may also adversely
affect the trading price of our common stock to the extent investors perceive a disadvantage in owning stock of a company with stockholders
who own such a significant percentage of our voting securities. Furthermore, any sales of common stock by these significant stockholders
in the public market, or the perception that these sales could occur, could depress the market price of our common stock.

21

There may be future sales of our common stock or other dilution
of our equity, which may adversely affect the market price of our common stock.

We are not restricted from issuing additional shares of common stock,
including securities that are convertible into or exchangeable for, or that represent a right to receive, common stock. Any issuance of
additional shares of our common stock or convertible securities will dilute the ownership interest of our existing shareholders. Sales
of a substantial number of shares of our common stock or other equity-related securities in the public market, or the perception that
these sales could occur, could depress the market price of our common stock and impair our ability to raise capital through the sale of
additional equity securities. We cannot predict the effect that future sales of our common stock or other equity-related securities would
have on the market price of our common stock.

We do not intend to pay dividends on our common stock for the